| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
|
Am J Hum Genet
|
2001
|
4.71
|
|
2
|
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
|
J Med Genet
|
2008
|
2.81
|
|
3
|
Germline SDHD mutation in familial phaeochromocytoma.
|
Lancet
|
2001
|
1.62
|
|
4
|
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
|
BJU Int
|
2010
|
1.60
|
|
5
|
A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics.
|
Br J Cancer
|
2001
|
1.56
|
|
6
|
Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20.
|
Eur J Cancer
|
1993
|
1.20
|
|
7
|
SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis.
|
Fam Cancer
|
2009
|
1.14
|
|
8
|
Variable deterioration in cortical function during insulin-induced hypoglycemia.
|
Diabetes
|
1985
|
1.05
|
|
9
|
What motivates interest in attending a familial cancer genetics clinic?
|
Fam Cancer
|
2003
|
1.04
|
|
10
|
Neurofibromatosis pseudogene amplification underlies euchromatic cytogenetic duplications and triplications of proximal 15q.
|
Hum Genet
|
1998
|
1.00
|
|
11
|
Topoisomerase I and II activity in human breast, cervix, lung and colon cancer.
|
Int J Cancer
|
1994
|
0.97
|
|
12
|
A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia.
|
Br J Cancer
|
1990
|
0.90
|
|
13
|
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).
|
J Exp Clin Cancer Res
|
2002
|
0.90
|
|
14
|
An investigation of the oxidation-reduction potential and of the effect of oxygen on the germination and outgrowth of Clostridium butyricum spores, using platinum electrodes.
|
J Appl Bacteriol
|
1973
|
0.88
|
|
15
|
Is colorectal surveillance indicated in patients with PTEN mutations?
|
Colorectal Dis
|
2012
|
0.87
|
|
16
|
Elevated levels of epidermal growth factor in a patient with tripe palms.
|
Br J Dermatol
|
1994
|
0.84
|
|
17
|
Identification of a cysteine residue at the active site of Escherichia coli isocitrate lyase.
|
Biochem J
|
1989
|
0.84
|
|
18
|
A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.
|
Br J Cancer
|
2004
|
0.83
|
|
19
|
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
|
Br J Cancer
|
2009
|
0.82
|
|
20
|
Autosomal dominant juvenile recurrent parotitis.
|
J Med Genet
|
1998
|
0.82
|
|
21
|
The effect of oxygen on the germination and outgrowth of Clostridium butyricum spores and changes in the oxidation-reduction potential of cultures.
|
J Appl Bacteriol
|
1974
|
0.81
|
|
22
|
Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
|
Transplant Proc
|
1988
|
0.80
|
|
23
|
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.
|
Br J Cancer
|
2011
|
0.79
|
|
24
|
Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
|
Transplant Proc
|
1988
|
0.78
|
|
25
|
Difetarsone in outpatient treatment of Trichuris trichiura infestation.
|
Arch Dis Child
|
1974
|
0.75
|
|
26
|
Optimizing the management of differentiated thyroid cancer.
|
Clin Oncol (R Coll Radiol)
|
2000
|
0.75
|
|
27
|
Inhibition of cholera-toxin-stimulated intestinal secretion by CGS 9343B in rats: a specific calmodulin inhibitor.
|
J Pediatr Gastroenterol Nutr
|
1989
|
0.75
|
|
28
|
Antiphospholipid syndrome presenting as cardiac failure.
|
QJM
|
2001
|
0.75
|
|
29
|
MRI evaluation of left ventricular hypertrophy in a canine model of aortic stenosis.
|
Invest Radiol
|
1990
|
0.75
|
|
30
|
Gene symbol: VHL.
|
Hum Genet
|
2007
|
0.75
|
|
31
|
Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
|
Transplant Proc
|
1988
|
0.75
|
|
32
|
Effects of CGS-13080, a thromboxane inhibitor, on pulmonary vascular resistance in patients after mitral valve replacement surgery.
|
Circulation
|
1988
|
0.75
|
|
33
|
Difetarsone in the treatment of Trichuris trichiura.
|
S Afr Med J
|
1973
|
0.75
|